Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Capsazepine attenuates inflammation-induced hyperalgesic responses

Sep. 15, 1998

Phase II trial of revolutionary migraine treatment completed ahead of schedule

Sep. 14, 1998

Roche to withdraw support for development of Kyowa Hakko's antiparkinsonian

Sep. 14, 1998

Neuroprotective effects of S-12024-2 demonstrated in rat model of neurodegeneration

Sep. 14, 1998

Synthelabo compounds act as 5-HT receptor ligands

Sep. 14, 1998

New anticonvulsant option now available in U.K.

Sep. 14, 1998

Genzyme General to commercialize and distribute Biogen's Avonex in Japan

Sep. 11, 1998

New anxiolytic PBI derivative discovered at R.W. Johnson

Sep. 11, 1998

Novel binary compounds with agonist-antagonist effects in vivo

Sep. 11, 1998

SB reports on potent analgesics with fewer side effects

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...